Alisha Reiss, MD
Surgery · Greenville, OHNPI 1740575190
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $280 of the $376 with a category attached, or 74.3%. 10 manufacturers reported payments, led by Braintree Laboratories, Inc. at 29.6% of the total. 2025 is the largest year on record at $184, 5.0 times the $37 reported in 2019. That places this record below the midpoint for surgery clinicians in OH, where the typical reported total is $1,531.
Across 17 payments — averaging $22.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Braintree Laboratories, Inc.$111
- Johnson & Johnson$68
- Hemosonics LLC$60
- Urgo Medical North America, LLC$35
- Organogenesis Inc.$28
- Medtronic$20
- plus $55 from 4 others
What the payments were for
- Food & beverage$28074%
- Gifts$9726%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Braintree Laboratories, Inc. | 5 | $111 |
| Johnson & Johnson | 3 | $68 |
| Hemosonics LLC | 2 | $60 |
| Urgo Medical North America, LLC | 1 | $35 |
| Organogenesis Inc. | 1 | $28 |
| Medtronic | 1 | $20 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| Myriad Genetic Laboratories, Inc. | 1 | $14 |
| Stryker | 1 | $13 |
| KCI USA, Inc. | 1 | $12 |
How this compares
$376 in reported general payments places this provider in the 30th percentile of 988 surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 64 | $3,769 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 15 | $181 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 31 | $137 |
| Pantoprazole Sodium | 16 | $87 |
Paid to pharmacies, not to this prescriber.
Other surgery in Greenville
- Jonathan ThompsonWest Chester$2.1M
- Raymond OndersCleveland$1.2M
- Neilendu KunduCleveland$808K
- Michael MearaColumbus$808K
- Chase WehrleCleveland$741K
- Craig JarrettCleveland$622K
- Greg StarleyCuyahoga Falls$594K
- Ihya GorgunCleveland$527K
- Marshall SpaldingColumbus$450K
- Jason ShoemakerDublin$344K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.